These data is consistent with previous study in clinic, which showed 100% partial response to HDAC inhibitor combined with CDDP-based chemotherapy in patients with inoperable stage III NSCLC.36 Mechanistically, the elimination of cancer stem cell by regulating HDAC and TRIB1 might be a reason. The gene discussed is HDAC9; the disease is non-small cell lung carcinoma.